145 related articles for article (PubMed ID: 30255943)
1. Harnessing snake venom phospholipases A
Almeida JR; Palacios ALV; Patiño RSP; Mendes B; Teixeira CAS; Gomes P; da Silva SL
Drug Dev Res; 2019 Feb; 80(1):68-85. PubMed ID: 30255943
[TBL] [Abstract][Full Text] [Related]
2. A novel synthetic peptide inspired on Lys49 phospholipase A
Almeida JR; Mendes B; Lancellotti M; Marangoni S; Vale N; Passos Ó; Ramos MJ; Fernandes PA; Gomes P; Da Silva SL
Eur J Med Chem; 2018 Apr; 149():248-256. PubMed ID: 29501945
[TBL] [Abstract][Full Text] [Related]
3. In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei.
Perumal Samy R; Pachiappan A; Gopalakrishnakone P; Thwin MM; Hian YE; Chow VT; Bow H; Weng JT
BMC Infect Dis; 2006 Jun; 6():100. PubMed ID: 16784542
[TBL] [Abstract][Full Text] [Related]
4. The Anthelmintic Effect on Strongyloides venezuelensis Induced by BnSP- 6, a Lys49-phospholipase A2 Homologue from Bothrops pauloensis Venom.
Rodrigues JP; Vasconcelos Azevedo FVP; Zoia MAP; Maia LP; Correia LIV; Costa-Cruz JM; de Melo Rodrigues V; Goulart LR
Curr Top Med Chem; 2019; 19(22):2032-2040. PubMed ID: 31340738
[TBL] [Abstract][Full Text] [Related]
5. Identification of the Molecular Determinants of the Antibacterial Activity of LmutTX, a Lys49 Phospholipase A
Diniz-Sousa R; Caldeira CAS; Kayano AM; Paloschi MV; Pimenta DC; Simões-Silva R; Ferreira AS; Zanchi FB; Matos NB; Grabner FP; Calderon LA; Zuliani JP; Soares AM
Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):413-423. PubMed ID: 29067765
[TBL] [Abstract][Full Text] [Related]
6. BaltPLA2: A New Phospholipase A2 from Bothrops Alternatus Snake Venom with Antiplatelet Aggregation Activity.
Dias EHV; Dos Santos Paschoal T; da Silva AP; da Cunha Pereira DF; de Sousa Simamoto BB; Matias MS; Santiago FM; Rosa JC; Soares A; Santos-Filho NA; de Oliveira F; Mamede CCN
Protein Pept Lett; 2018; 25(10):943-952. PubMed ID: 30289061
[TBL] [Abstract][Full Text] [Related]
7. Structural and pharmacological features of phospholipases A2 from snake venoms.
de Paula RC; Castro HC; Rodrigues CR; Melo PA; Fuly AL
Protein Pept Lett; 2009; 16(8):899-907. PubMed ID: 19689416
[TBL] [Abstract][Full Text] [Related]
8. Snake venom phospholipases A(2): a novel tool against bacterial diseases.
Samy RP; Gopalakrishnakone P; Stiles BG; Girish KS; Swamy SN; Hemshekhar M; Tan KS; Rowan EG; Sethi G; Chow VT
Curr Med Chem; 2012; 19(36):6150-62. PubMed ID: 22963667
[TBL] [Abstract][Full Text] [Related]
9. Phospholipases A2: unveiling the secrets of a functionally versatile group of snake venom toxins.
Gutiérrez JM; Lomonte B
Toxicon; 2013 Feb; 62():27-39. PubMed ID: 23025922
[TBL] [Abstract][Full Text] [Related]
10. CoaTx-II, a new dimeric Lys49 phospholipase A2 from Crotalus oreganus abyssus snake venom with bactericidal potential: Insights into its structure and biological roles.
Almeida JR; Lancellotti M; Soares AM; Calderon LA; Ramírez D; González W; Marangoni S; Da Silva SL
Toxicon; 2016 Sep; 120():147-58. PubMed ID: 27530662
[TBL] [Abstract][Full Text] [Related]
11. Insights into the antiviral activity of phospholipases A
Teixeira SC; Borges BC; Oliveira VQ; Carregosa LS; Bastos LA; Santos IA; Jardim ACG; Melo FF; Freitas LM; Rodrigues VM; Lopes DS
Int J Biol Macromol; 2020 Dec; 164():616-625. PubMed ID: 32698062
[TBL] [Abstract][Full Text] [Related]
12. Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential.
Marcussi S; Sant'Ana CD; Oliveira CZ; Rueda AQ; Menaldo DL; Beleboni RO; Stabeli RG; Giglio JR; Fontes MR; Soares AM
Curr Top Med Chem; 2007; 7(8):743-56. PubMed ID: 17456038
[TBL] [Abstract][Full Text] [Related]
13. Phospholipases A
Jia Y; Villarreal J
Toxicon; 2018 Sep; 151():1-4. PubMed ID: 29928892
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes.
Perumal Samy R; Gopalakrishnakone P; Thwin MM; Chow TK; Bow H; Yap EH; Thong TW
J Appl Microbiol; 2007 Mar; 102(3):650-9. PubMed ID: 17309613
[TBL] [Abstract][Full Text] [Related]
15. Expression, purification and virucidal activity of two recombinant isoforms of phospholipase A
Russo RR; Dos Santos Júnior NN; Cintra ACO; Figueiredo LTM; Sampaio SV; Aquino VH
Arch Virol; 2019 Apr; 164(4):1159-1171. PubMed ID: 30809709
[TBL] [Abstract][Full Text] [Related]
16. Anti-platelet aggregation activity of two novel acidic Asp49-phospholipases A
Sobrinho JC; Kayano AM; Simões-Silva R; Alfonso JJ; Gomez AF; Gomez MCV; Zanchi FB; Moura LA; Souza VR; Fuly AL; de Oliveira E; da Silva SL; Almeida JR; Zuliani JP; Soares AM
Int J Biol Macromol; 2018 Feb; 107(Pt A):1014-1022. PubMed ID: 28951306
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of analgesic action of Gln49-PLA(2) from Gloydius ussurensis snake venom.
Zhang Y; Jiang B; Li W; Zhou C; Ji F; Xie Q; Sun X; An L; Bao Y
Appl Biochem Biotechnol; 2010 Mar; 160(3):773-9. PubMed ID: 19277489
[TBL] [Abstract][Full Text] [Related]
18. Snake venoms: attractive antimicrobial proteinaceous compounds for therapeutic purposes.
de Oliveira Junior NG; e Silva Cardoso MH; Franco OL
Cell Mol Life Sci; 2013 Dec; 70(24):4645-58. PubMed ID: 23657358
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial actions of secreted phospholipases A2. Review.
Nevalainen TJ; Graham GG; Scott KF
Biochim Biophys Acta; 2008; 1781(1-2):1-9. PubMed ID: 18177747
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral Potential of Snake Venom Phospholipases A2 and Synthetic Peptides.
Sobrinho JC; Simões-Silva R; Holanda RJ; Alfonso J; Gomez AF; Zanchi FB; Moreira-Dill LS; Grabner AN; Zuliani JP; Calderon LA; Soares AM
Curr Pharm Biotechnol; 2016; 17(14):1201-1212. PubMed ID: 27604356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
